Plasma Endothelin-1 Levels in Patients with Disseminated Intravascular Coagulation
- 23 May 1991
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 324 (21) , 1516-1517
- https://doi.org/10.1056/nejm199105233242121
Abstract
Vascular endothelial damage plays an important part in the pathophysiology of disseminated intravascular coagulation.1 , 2 It may mediate a variety of triggering events to initiate intravascular coagulation and platelet aggregation, which in turn lead to further endothelial destruction. Recently, a potent vasoconstrictor peptide, endothelin-1, has been isolated from the culture medium of vascular endothelial cells.3 Endothelin-1 is present in human plasma, and its levels are elevated in certain pathologic states.4 , 5 To determine whether endothelin-1 is of importance in disseminated intravascular coagulation, we measured circulating levels of endothelin-1 and big endothelin-1, a precursor peptide of endothelin-1, in patients with this disorder.Keywords
This publication has 5 references indexed in Scilit:
- Endothelin Family in Human Plasma and Cerebrospinal FluidJournal of Clinical Endocrinology & Metabolism, 1990
- A sensitive sandwich-enzyme immunoassay for human endothelinJournal of Immunological Methods, 1989
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988
- The Regulation of Natural Anticoagulant PathwaysScience, 1987
- Disseminated intravascular coagulation and related syndromes: Etiology, pathophysiology, diagnosis, and managementAmerican Journal of Hematology, 1978